Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2026
      • Dates and Deadlines
      • Exhibits
      • Housing and Travel
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2025
      • Neuroscience 2024
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (466)
Filter
191 - 200 of 678 results
  • Abstract
    3-D cytoarchitectonic parcellation of the human thalamus: correlation with postmortem MRI.
    For a more accurate determination of a thalamic lesion or target for neurosurgical intervention as well as for a better interpretation of functional MRIs and PET studies, we are currently preparing a 3-D atlas of the human thalamus. For the present study, 5 brains have been used from human subjects without known neurological or psychiatric deficits. Postmortem MRIs were taken before brains were paraffin embedded, cut in the frontal plane at a thickness of 20 μm and stained with Gallyas modification for neuronal cell bodies. Cytoarchitectonic criteria, in particular cell density, cell size and shape, as well as arrangement of cells, were used to delineate the various thalamic nuclei in sections taken at an interval of about 1 mm. The mammillary bodies, mammillothalamic tract, habenula, subthalamic nucleus, and nucleus ruber were included in the 3-D atlas as additional landmarks. The Gallyas-stained sections with the delineated cell masses were superimposed on the postmortem 3-D MRIs after local affine trans...
    Nov 8, 2000
  • Abstract
    Functional MRI of anesthetized monkeys using three dimensional structure from motion stimuli.
    Functional magnetic resonance imaging (fMRI) has previously been used in humans to show functional separation between activation of dorsal and ventral visual areas using three dimensional structure from motion (SFM) stimuli (Naumer et al., Human Brain Mapping Abstr. 2000). We used identical stimuli to measure BOLD signals in ketamine anesthetized macaque monkeys (N=5). This imaging technique has recently been applied to monkeys anesthetized with isoflurane in a high magnetic field (4.7 T) scanner (Logothetis et al., 1999) and to awake monkeys in a standard 1.5T scanner (Vanduffel et al., Soc. Neurosci. Abst. 1998). Our fMRI study was performed at 1.5T using standard EPI sequences (Siemens Magnetom Vision, 8-16 slices, voxel size: 1.6 - 3.2 mm3, TR = 2-3 s). The head of the anesthetized monkeys was restrained in sphinx position with bolt implant and custom head holder or in supine position with cushions. Eye refraction was corrected with contact lenses. FMRI signals was analyzed using BrainVoyager 2000 incl...
    Nov 8, 2000
  • Abstract
    MRI measures of brain atrophy in multiple sclerosis: associations with glucocorticoid treatment.
    Brain atrophy is a consistent finding in patients with multiple sclerosis (MS). The present study investigated if the amount of glucocorticoids (GC), administered as treatment for acute episodes of MS, can serve as an additional explanatory factor for this finding. From a total of 379 patients with relapsing-remitting MS, baseline and two year follow up Magnetic Resonance Imaging (MRI) scans of 27 cases were selected. During the trial period, 14 patients had received high doses of glucocorticoid treatment, while 13 patients were without treatment. Subjects in both groups were matched for gender, age, and evaluation on the Expanded Disability Status Scale (EDSS) at study begin (0-4,5). T1 weighted images with 3mm axial contiguous slices were acquired. All MR images were transformed into standard stereotaxic space. Volumetric analyses were performed for white matter, gray matter, hippocampus, and ventricles using both manual and automatic segmentation procedures. The GC treatment group showed significant atr...
    Nov 7, 2000
  • Abstract
    Functional MRI of human primary olfactory cortex, rate-encoding versus temporal-encoding.
    Functional magnetic resonance imaging (fMRI) of primary olfactory cortex (POC) has yielded inconsistent results. Odorant-induced POC activity is present at times and absent at others even within the same lab using the same task. Most statistical models used to analyze fMRI data rely on two assumptions: 1. a monotonic transform from stimulus magnitude to neural activity quantity, and 2. a linear transform from neural activity quantity to MR signal magnitude. Whereas the latter has been demonstrated for MR (Boynton et al 1996), the former has not been demonstrated for POC. An equally viable alternative to a rate-encoding model is a temporal-encoding model. Models of temporal-encoding imply no monotonic transform from stimulus magnitude to neural activity quantity. Thus, fMRI is a potentially invalid measure of POC activity under temporal-encoding models. To address this issue we set out to quantify the stimulus magnitude dependence in POC in thirty subjects. An olfactometer generated low, medium and high con...
    Nov 11, 2003
  • Abstract
    Comparisons of white matter damage in HIV and normal aging on MRI.
    Significant white matter signal alteration is a frequent finding in both individuals with HIV (HIV+) and normal elderly subjects seronegative for HIV (HIV-). As the incidence of HIV in older individuals increases, the detection of white matter abnormalities (WMA) related to HIV in the elderly presents a challenge. The present study compared WMA in these groups using MRI morphometry. Analyses were performed on 122 HIV- subjects aged 20 to 99 years, and 42 HIV+ subjects aged 25 to 55 years. Volumes of WMA in the HIV+ group resembled those of HIV- individuals who were more than 30 years older. To investigate whether there were regional differences in WMA, three groups were compared: a younger HIV- group aged 25 to 50 (HIV-Y), HIV+ subjects in this age range (HIV+Y), and HIV- individuals aged 60-75 (HIV-O). Both HIV-O and HIV+Y groups exhibited significant increases in the volume of WMA, relative to the HIV-Y group, across multiple regions including the 4 cerebral lobes and a region of deep white matter surrou...
    Nov 9, 2003
  • Mapping the Microstructure and Striae of the Human Olfactory Tract with Diffusion MRI | Journal of Neuroscience
    The human sense of smell plays an important role in appetite and food intake, detecting environmental threats, social interactions, and memory processing. However, little is known about the neural circuity supporting its function. The olfactory tracts project from the olfactory bulb along the base of the frontal cortex, branching into several striae to meet diverse cortical regions. Historically, using diffusion magnetic resonance imaging (dMRI) to reconstruct the human olfactory tracts has been prevented by susceptibility and motion artifacts. Here, we used a dMRI method with readout segmentation of long variable echo-trains (RESOLVE) to minimize image distortions and characterize the human olfactory tracts in vivo . We collected high-resolution dMRI data from 25 healthy human participants (12 male and 13 female) and performed probabilistic tractography using constrained spherical deconvolution (CSD). At the individual subject level, we identified the lateral, medial, and intermediate striae with their re...
    Jan 5, 2022 Shiloh L. Echevarria-Cooper
  • Abstract
    Second-order motion detection in humans: A magnetoencephalography and functional MRI study.
    Humans detect motions of images defined not only by luminance difference (first-order) but images segregated by the second-order characteristics such as texture, contrast, and so on. There have been few electrophysiological studies addressed on the mechanism underlying the second-order motion detection. First, we measured the magnetoencephalographic (MEG) response to the second-order motion defined by the sinusoidally modulated dots speeds but there was no obvious responses detected whereas the responses to the first-order sinusoidal grating at the same speed (2.6 deg/s) were found peaking at about 310 ms. Second, we measured the MEG responses to the apparent motions of the square areas. The areas were defined by the three characteristics: difference in the dots speeds (second-order apparent motion; SA), luminance of the dots (first-order; FA), and dots speeds and luminance (mixed; MA). For all the stimuli, MEG latencies decreased and the amplitudes increased as the motion distance increased. The latencies...
    Nov 6, 2002
  • Abstract
    MRI evidence of reduced cortical gray matter in familial bipolar I disorder.
    Despite neuropathological evidence for significant neuronal and glial cell reductions in specific cortical regions in bipolar disorder, MRI studies have not consistently demonstrated either global or regional cortical gray matter reductions. Several MRI studies have suggested that brain abnormalities may be more prominent in familial mood disorders. Therefore, this study examined DSE and MP-RAGE MRI images of 20 familial bipolar I subjects (age 38.9 ± 9.4 years) and 45 control subjects (age 34.6 ± 10.4 years) utilizing quantitative MRI tissue segmentation and Talairach-atlas based volumetric techniques. ANCOVA with age, sex, and intracranial volume as covariates was used for statistical analysis. The bipolar I disorder group demonstrated significantly increased sulcal (p=0.010) and ventricular CSF (p=0.015), as well as decreased white matter (p=0.043) and cortical gray matter(p=0.009). To further investigate the cortical gray matter reduction, Talairach atlas-based regional voluming revealed significantly ...
    Nov 5, 2002
  • Abstract
    MOLECULAR TARGETING OF ALZHEIMER'S AMYLOID PLAQUES FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING.
    Smart molecular probes for both diagnostic and therapeutic purposes are expected to provide quantum advances in clinical medicine and biomedical research. We describe such a probe that targets β-amyloid plaques of Alzheimer’s disease and is detectable by magnetic resonance imaging (MRI) because of contrast imparted by gadolinium labeling. Three essential properties are shown to exist in this smart molecular probe, putrescine-gadolinium-amyloid-β peptide: 1) transport across the blood-brain-barrier following intravenous injection which is conferred by the polyamine moiety, 2) binding to plaques with high affinity by the putrescine-labeled amyloid-β peptide, and 3) MRI detectability conferred by the contrast agent, gadolinium. MRI was performed on ex vivo tissue specimens at a spatial resolution approximating plaque size (62.5 μm3), in order to prove the concept that the probe can selectively enhance plaques when administered intravenously. The plaque-to-background tissue contrast-to-noise ratio, that was pr...
    Nov 4, 2002
  • Chromatic Light Adaptation Measured using Functional Magnetic Resonance Imaging | Journal of Neuroscience
    Sensitivity changes, beginning at the first stages of visual transduction, permit neurons with modest dynamic range to respond to contrast variations across an enormous range of mean illumination. We have used functional magnetic resonance imaging (fMRI) to investigate how these sensitivity changes are controlled within the visual pathways. We measured responses in human visual area V1 to a constant-amplitude, contrast-reversing probe presented on a range of mean backgrounds. We found that signals from probes initiated in the L and M cones were affected by backgrounds that changed the mean absorption rates in the L and M cones, but not by background changes seen only by the S cones. Similarly, signals from S cone-initiated probes were altered by background changes in the S cones, but not by background changes in the L and M cones. Performance in psychophysical tests under similar conditions closely mirrored the changes in V1 fMRI signals. We compare our data with simulations of the visual pathway from phot...
    Sep 15, 2002 Alex R. Wade
  • Previous
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next

Featured

  • Congratulations to the 2026 FENS Forum Award winners!
  • 2026 Peter Seeburg Integrative Neuroscience Prize Awarded to Amy Arnsten
  • Upcoming Webinar: Positive Choice Bias and Resilience
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience